Prelude Capital Management’s ADARx Pharmaceuticals ADRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$774K Buy
+38,800
New +$776K 0.06% 390

Other funds holding ADRX

Prelude Capital Management's ADRX Position: Q3 2026 in Review

Prelude Capital Management opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 38,800 shares worth $774K. The stake represents 0.06% of the portfolio and ranks #390 among its holdings.

62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.

  • Prelude Capital Management held 38,800 shares of ADARx Pharmaceuticals worth $774K as of Q3 2026.
  • ADARx Pharmaceuticals was a new Prelude Capital Management position in Q3 2026.
  • ADARx Pharmaceuticals made up 0.06% of Prelude Capital Management's portfolio in Q3 2026, its #390 holding.
  • 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.

Based on Prelude Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.